{
  "question_stem": {
    "en": "A 49-year-old woman is brought to the emergency department with squeezing chest pain and profuse sweating for the last 2 hours. Medical history includes diet-controlled type 2 diabetes mellitus. ECG reveals ST-segment elevation in leads I, aVL, and V1-V4. The patient is immediately taken to the cardiac catheterization laboratory, where she is found to have complete occlusion of the left anterior descending coronary artery. The blockage is opened with percutaneous coronary intervention with stenting, but afterward she experiences recurrent and sustained episodes of ventricular arrhythmia. She is treated with an antiarrhythmic agent that preferentially binds to rapidly depolarizing and ischemic ventricular myocardial fibers and has minimal effect on normal ventricular myocardium.",
    "zh": "一名49岁的女性因挤压性胸痛和大量出汗2小时被送入急诊科。病史包括饮食控制的2型糖尿病。心电图显示导联I、aVL和V1-V4 ST段抬高。患者立即被送往心脏导管插入实验室，发现其左前降支冠状动脉完全闭塞。通过经皮冠状动脉介入治疗并置入支架打开了阻塞，但之后她出现了反复且持续的室性心律失常发作。她接受了一种抗心律失常药物的治疗，该药物优先与快速去极化和缺血性心室心肌纤维结合，对正常的心室心肌影响很小。"
  },
  "question": {
    "en": "Which of the following agents was most likely used in this patient?",
    "zh": "以下哪种药物最有可能用于该患者？"
  },
  "options": {
    "A": {
      "en": "Adenosine",
      "zh": "腺苷"
    },
    "B": {
      "en": "Digoxin",
      "zh": "地高辛"
    },
    "C": {
      "en": "Diltiazem",
      "zh": "地尔硫卓"
    },
    "D": {
      "en": "Ibutilide",
      "zh": "伊布利特"
    },
    "E": {
      "en": "Lidocaine",
      "zh": "利多卡因"
    },
    "F": {
      "en": "Metoprolol",
      "zh": "美托洛尔"
    },
    "G": {
      "en": "Procainamide",
      "zh": "普鲁卡因胺"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "This patient sustained an anterolateral ST elevation myocardial infarction (MI) with successful reperfusion following percutaneous coronary intervention. VENTRICULAR ARRHYTHMIAS (premature beats, ventricular tachycardia/fibrillation) are common in the first 24-48 hours after MI and may be treated with antiarrhythmic medications (eg, amiodarone, lidocaine).\n\nClass IB drugs like lidocaine are the weakest sodium channel blockers (dissociate the fastest) compared to other class I antiarrhythmics. They predominantly bind to sodium channels in the inactivated state, and dissociation from the channels occurs so rapidly that they have a negligible effect on QRS duration in normal cardiac tissues. Ischemic myocardium has higher than normal (less negative) resting membrane potential, which delays voltage-dependent recovery of sodium channels from the inactivated to the resting state. This allows increased binding of class IB agents; therefore, class IB antiarrhythmics are highly efficacious in inhibiting ischemia-induced ventricular arrhythmias.\n\n(Choice A) Adenosine causes transient conduction delay through the atrioventricular (AV) node and is used in the acute treatment of paroxysmal supraventricular tachycardia; it is not indicated in ventricular arrhythmias.\n\n(Choice B) Digoxin enhances vagal tone and leads to an increased effective refractory period and decreased conduction velocity through the AV node. These actions are useful in management of patients with supraventricular tachyarrhythmias.\n\n(Choice C) Diltiazem is a class IV antiarrhythmic drug (calcium channel blocker) that slows the sinus rate, prolongs conduction through the AV node, and depresses myocardial contractility (ie, a negative inotropic effect). It is primarily used as a rate-control agent for the management of atrial tachyarrhythmias (eg, atrial flutter, atrial fibrillation).\n\n(Choice D) Ibutilide is a class III antiarrhythmic drug (potassium channel blocker) and is occasionally used for acute termination of atrial flutter and fibrillation. It prolongs the QT interval and increases the risk of polymorphic ventricular tachycardia (torsades de pointes).\n\n(Choice F) Metoprolol is a selective beta-1 receptor antagonist (class II antiarrhythmic) that acts as a negative inotropic and chronotropic agent (decreased myocardial contractility and heart rate). Beta blockers are frequently used in patients with acute or recent MI; they reduce the risk of ventricular arrhythmia by decreasing automaticity and reduce the size of ischemic myocardium by decreasing myocardial oxygen demand.\n\n(Choice G) Class IA antiarrhythmic drugs (eg, procainamide, disopyramide) tend to bind to sodium channels in the open state and are more specific for suppressing arrhythmias arising from areas of normal automaticity (lidocaine is more specific to inactivated channels that are more predominant in ischemic myocardium). Class IA agents also have significant potassium channel-blocking activity, leading to prolongation of action potential and an increased risk of ventricular arrhythmias.",
    "zh": "该患者发生了前侧壁ST段抬高型心肌梗死（MI），经皮冠状动脉介入治疗后成功再灌注。室性心律失常（早搏、室性心动过速/颤动）在MI后24-48小时内很常见，可用抗心律失常药物（如胺碘酮、利多卡因）治疗。\n\n与其它I类抗心律失常药相比，利多卡因等IB类药物是最弱的钠通道阻滞剂（解离最快）。它们主要与失活状态的钠通道结合，并且与通道的解离发生得如此迅速，以至于它们对正常心肌组织的QRS波时间影响可以忽略不计。缺血性心肌具有高于正常水平（负值较小）的静息膜电位，这延迟了钠通道从失活状态到静息状态的电压依赖性恢复。这使得IB类药物的结合增加；因此，IB类抗心律失常药在抑制缺血引起的心室心律失常方面非常有效。\n\n(选项A) 腺苷通过房室(AV)结引起短暂的传导延迟，用于阵发性室上性心动过速的急性治疗；它不适用于室性心律失常。\n\n(选项B) 地高辛增强迷走神经张力，导致房室结的有效不应期延长和传导速度减慢。这些作用有助于治疗室上性快速性心律失常。\n\n(选项C) 地尔硫卓是一种IV类抗心律失常药物（钙通道阻滞剂），可减慢窦性心率、延长通过房室结的传导时间，并抑制心肌收缩力（即负性肌力作用）。它主要用作控制心率的药物，用于治疗房性快速性心律失常（如房扑、房颤）。\n\n(选项D) 伊布利特是一种III类抗心律失常药物（钾通道阻滞剂），偶尔用于急性终止房扑和房颤。它会延长QT间期，并增加多形性室性心动过速（尖端扭转型室速）的风险。\n\n(选项F) 美托洛尔是一种选择性β-1受体拮抗剂（II类抗心律失常药），可作为负性肌力和负性变时药物（降低心肌收缩力和心率）。β受体阻滞剂常用于近期或急性心肌梗死的患者；它们通过降低自律性来降低室性心律失常的风险，并通过降低心肌耗氧量来减少缺血心肌的范围。\n\n(选项G) IA类抗心律失常药（如普鲁卡因胺、双异丙吡胺）倾向于与开放状态的钠通道结合，并且更特异性地用于抑制源于正常自律性区域的心律失常（利多卡因对缺血心肌中占主导地位的失活通道更具特异性）。IA类药物也具有显著的钾通道阻滞活性，导致动作电位延长，并增加室性心律失常的风险。"
  },
  "summary": {
    "en": "This question assesses the appropriate antiarrhythmic drug for ventricular arrhythmias following myocardial infarction, focusing on the mechanism of action and selectivity for ischemic tissue. It tests knowledge of different antiarrhythmic classes and their specific indications. \n\nThe key to solving this question is recognizing that lidocaine (a Class IB antiarrhythmic) preferentially binds to ischemic tissue and rapidly dissociates, making it effective for ischemia-induced ventricular arrhythmias. Understanding the mechanisms of action of other antiarrhythmics helps to eliminate incorrect options.",
    "zh": "本题评估心肌梗死后室性心律失常的合适抗心律失常药物，重点关注其作用机制和对缺血组织的特异性。它测试了对不同抗心律失常药物类别及其具体适应症的了解。\n\n解决本题的关键在于认识到利多卡因（一种IB类抗心律失常药）优先与缺血组织结合并迅速解离，使其对缺血引起的心室心律失常有效。了解其他抗心律失常药物的作用机制有助于排除不正确的选项。"
  },
  "tags": "Ventricular arrhythmia; Myocardial infarction; Antiarrhythmic drugs; Lidocaine; Class IB antiarrhythmics; Cardiology; Emergency medicine; Ischemia; Sodium channel blockers",
  "category": "CVS",
  "question_id": "900",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\CVS 23\\900",
  "extracted_at": "2025-11-05T12:19:29.587160",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T17:32:27.090328",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}